Review



breast pam50 subtyping assay  (Bioclassifier LLC)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Bioclassifier LLC breast pam50 subtyping assay
    Breast Pam50 Subtyping Assay, supplied by Bioclassifier LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/breast+pam50+subtyping+assay/breast+pam50+subtyping+assay/pm40624726-463-24-10
    Average 90 stars, based on 1 article reviews
    breast pam50 subtyping assay - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Defining the regulatory logic of breast cancer using single-cell epigenetic and transcriptome profiling.
    Article Snippet: DECLARATION OF INTERESTS C.M.P is an equity stockholder and consultant of BioClassifier LLC; C.M.P is also listed as an inventor on patent applications for the Breast PAM50 Subtyping assay.

    Article Title: Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasets.
    Article Snippet: C.M.P. is an equity stockholder and consultant of BioClassifier LLC; C.M.P. is also listed as an inventor on patent applications for the Breast PAM50 Subtyping assay.

    Article Title: Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis.
    Article Snippet: CMP is an equity stock holder and consultant of BioClassifier LLC; CMP is also listed as an inventor on patent applications for the Breast PAM50 Subtyping assay.

    Article Title: Overexpression of TSG101 causes the development of adenosquamous mammary carcinoma.
    Article Snippet: Competing interests C.M.P. is an equity stockholder and consultant of BioClassifier LLC; C.M.P is also listed as an inventor on patent applications for the Breast PAM50 Subtyping assay.

    Article Title: B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancer.
    Article Snippet: CMP is an equity stockholder and consultant of BioClassifier LLC; CMP is also listed as an inventor on patent applications for the Breast PAM50 subtyping assay.

    Article Title: Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials.
    Article Snippet: : equity stock holder and consultant of BioClassifier LLC; listed as an inventor on patent applications for the Breast PAM50 Subtyping assay; equity stock holder and consultant of Reveal Genomics.

    Article Title: Visual Intratumor Heterogeneity and Breast Tumor Progression.
    Article Snippet: C.M.P is an equity stockholder and consultant of BioClassifier LLC; C.M.P is also listed as an inventor on patent applications for the Breast PAM50 Subtyping assay.

    Article Title: Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy.
    Article Snippet: Charles M. Perou has patent #Breast PAM50 Subtyping assay with royalties paid to BioClassifier.



    Similar Products

    breast pam50 subtyping assay  (Bioclassifier LLC)
    90
    Bioclassifier LLC breast pam50 subtyping assay
    Breast Pam50 Subtyping Assay, supplied by Bioclassifier LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/breast+pam50+subtyping+assay/breast+pam50+subtyping+assay/pm40624726-463-24-10
    Average 90 stars, based on 1 article reviews
    breast pam50 subtyping assay - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    breast cancer gene expression subtyping by pam50  (Veracyte Inc)
    90
    Veracyte Inc breast cancer gene expression subtyping by pam50
    Breast Cancer Gene Expression Subtyping By Pam50, supplied by Veracyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/breast+pam50+subtyping+assay/prosigna++breast+cancer+prognostic+gene+signature+assay/pm38236702-157-6-9
    Average 90 stars, based on 1 article reviews
    breast cancer gene expression subtyping by pam50 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results